In vitro and in vivo postmarketing surveillance of valsartan, alone or in combination with amlodipine or hydrochlorthiazide, among Palestinian hypertensive patients

Abdel Naser Zaid, Masshour Ghanem, Dua`a Shweiki, Hala Shtewi, Raja` Shaheen, Sondos Al Helaly, Zeina Khayyat, Rowa’a Al Ramahi, Saed Zyoud
  • Therapeutics and Clinical Risk Management, September 2016, Dove Medical Press
  • DOI: 10.2147/tcrm.s110727

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

The following have contributed to this page: Abdel Naser Zaid and Dr Sa'ed Zyoud